Health News Releases

March 12, 17:15

Pharmaceutical Industry Issues Call for Collective Action to Address the Rising Global Burden of Chronic Disease

Ahead of a major UN milestone (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.who.int%2Fteams%2Fnoncommunicable-diseases%2Fon-the-road-to-2025%23Shaping%2520a%2520transformative

March 12, 11:05

Rigaku Wins Diana Nyyssonen Memorial Best Paper Award with Method for Inspecting and Measuring Defects in 3D Flash Memory

Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) has won the Diana Nyyssonen Memorial Best Paper Award (herei

March 11, 16:40

Kenvue Announces Three New Appointments to Board of Directors

Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sarah Hofstetter, President of Profitero,

March 07, 13:30

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54216036&newsitemid=20250227911272&lan=en-US&anchor=BeiGene&index=1&md5=e2cdff0a0d83750ab7730987260

March 07, 11:45

Novotech Releases Hepatitis B Global Clinical Trial Landscape Report 2025

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released its

March 06, 17:30

InterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record

InterSystems (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.intersystems.com&esheet=54216543&newsitemid=20250304321284&lan=en-US&anchor=InterSystems&index=1&md5=2a1879be82b01b2

March 06, 15:45

Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency[1], and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2024, delivering strong results for another consecutive year while maki

March 06, 11:30

Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products

Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercode™ single cell chromatin prod

March 06, 10:10

Aster Guardians Global Nursing Award 2025 Worth $250,000 Extends Nomination Deadline to 9th March

Aster Guardians Global Nursing Award 2025 - an initiative by the leading integrated healthcare provider, Aster DM Healthcare, has extended the deadline for submission of nominations to 9th March, 2025

March 04, 10:49

Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX (https://www.protagonist-inc.com/)) and Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced positive top

March 03, 13:20

New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits

Baszucki Group today announced a new pilot study on a ketogenic diet in bipolar disorder. “For the first time in years, I felt like my brain was finally running on the right fuel,” said one of the stu

March 03, 12:00

Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema

Astria Therapeutics, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fastriatx.com%2F&esheet=54215940&newsitemid=20250227320197&lan=en-US&anchor=Astria+Therapeutics%2C+Inc.&inde

March 03, 10:40

SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order

Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court

February 28, 16:30

Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East

Cynosure Lutronic, a global leader in the energy-based devices market, has entered into a multi- country distribution agreement with Amico Aesthetics, a leader in providing world-class medical devices

February 28, 11:25

The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity

The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in

February 27, 14:00

Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results

Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide delayed-

February 26, 16:48

BROADMEDI and KHCA Sign Strategic MOU to Enhance Medical Tourism Services

BROADMEDI, a leading medical tourism platform of CREINNOS, has signed a strategic Memorandum of Understanding (MOU) with the Korea Hospital Coordinator Association (KHCA) to enhance service quality in

February 24, 16:43

KEYRESEARCH Launches ‘Aco-Alpha’ Nutr Supplement for Kids and Sells Out on First Day

KEYRESEARCH, a prominent name in health, announced the successful launch of its new product, ‘Aco-Alpha,’ on the 24th. It has been sold out immediately thanks to overwhelming demand. This sellout high

February 23, 13:20

ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)

Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. (“PharmaEssentia”) and AOP Orphan Pharmaceuti

February 23, 11:50

Erectile Dysfunction: The PelviTouch Revolution Comes From DEKA’s Italian Technology

DEKA Laser, a subsidiary of El.En. S.p.A., a company operating in the Laser and Energy-Based Devices market, listed on Borsa Italiana’s Euronext STAR Milan (“STAR”), and a global leader in medical tec

February 23, 11:15

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ - a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healt

February 21, 10:40

Ferrer is the Highest-performing Pharmaceutical Company in the World for Social and Environmental Impact According to B Corp

Spanish pharmaceutical company Ferrer has reaffirmed its status as a B Corp, an international certification awarded to companies that operate with a business model centered on positive impact and meet

February 21, 09:40

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round. Enki

February 20, 09:17

Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing

Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 million

February 19, 15:15

Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete

February 19, 11:00

Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea

Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel ther

February 18, 15:20

Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis

Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedic have granted the marketing authorization of nemolizumab for the treatment of bo

February 16, 09:30

Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the

February 14, 15:45

Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now a

February 11, 11:30

PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality

PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes that will seek to accelerate the manufacturi

February 06, 09:35

Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products

Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54199035&newsitemid=20250204152815&lan=en-US&anchor=Parse+Biosciences&index=1&md

February 04, 16:35

ELIQUENT Life Sciences Announces: Rob Wojciechowski Named Chief Operations Officer

ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the appointment of Rob Wojciechowski as Chief Operations Officer (COO). In this new role, R

January 31, 17:24

GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand

GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on

January 31, 15:37

IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess™)

Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of aest

January 31, 14:25

Ferrer is Recognized for Its Best-in-class Ethics and Compliance Program

Ferrer has achieved Compliance Leader Verification™, the prestigious recognition granted by Ethisphere, which distinguishes the pharmaceutical company as a global leader in upholding ethical and respo

January 31, 13:12

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.takeda.com&esheet=54196039&newsitemid=20250129509380&lan=en-US&anchor=Takeda&index=1&md5=98fdda2da61995100aa6dbd136297ebe)

January 31, 09:30

Brandnew Clinic Celebrates 15th Anniversary with Exclusive Promotions and Events

Brandnew Clinic (www.brandnewclinic.com) has announced a month-long celebration in February to commemorate its 15th anniversary and express gratitude to its loyal clients. Under the leadership of Dr.

January 30, 15:50

Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth

Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54191699&newsitemid=20250127274764&lan=en-US&anc

January 30, 15:35

Galderma Demonstrates Injectable Aesthetics Leadership in Medication-Driven Weight Loss With New Research and First International Consensus-Based Guidelines

Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven weight loss on the skin and the importance of factoring in aesthetic treatment goal

January 30, 11:55

ImmunoMet Therapeutics Presents Updated Clinical Data from Phase 1b Study of Lixumistat in Pancreatic Cancer at ASCO-GI Meeting

ImmunoMet Therapeutics, Inc., (“ImmunoMet”, or the “Company”), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data update from t

January 24, 11:15

LTIMindtree Renews its Strategic Alliance with the Association of American Medical Colleges (AAMC)

LTIMindtree (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ltimindtree.com%2F&esheet=54183242&newsitemid=20250120318350&lan=en-US&anchor=LTIMindtree&index=1&md5=f780cd94b90cf27

January 23, 15:24

IMCAS 2025: Galderma’s Broad Presence and New Data on Recently Launched Products Restylane® SHAYPE™ and Relfydess® Reaffirm Its Category Leadership

Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025 on January 30 - February 1 in Paris, F

January 23, 11:10

Novotech Releases Comprehensive Report on Oncolytic Virus Therapy

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel th

January 22, 14:35

New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide

Women’s cancer testing has declined globally, according to the latest Hologic Global Women’s Health Index (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwomenshealthindex.com&esheet

January 21, 11:30

Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors

Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a dual-payload bispecific antibody-drug conjugate (BsAD2C) program. This co

January 17, 14:30

Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials

Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for Trip

January 17, 08:47

SINOVAC Issues Statement Regarding Privy Council Judgment

Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Judicial Committee of the Privy Council in London, E

January 15, 11:15

Mesmerise to collaborate with Mayo Clinic to Transform Medical Education and Healthcare Workforce Training

Mesmerise is proud to announce the creation of NeuRealities, Inc., a transformative company designed to revolutionize medical education and healthcare training. As part of a know-how agreement with Ma

January 14, 16:20

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane® Lyft™ or Contour™ in combination with Sculptra® in patients with medication-driven weig

January 14, 16:10

Zepp Health to Showcase Groundbreaking Innovations at CES Pepcom & ShowStoppers Media Events

--CES -- Zepp Health Corporation (NYSE: ZEPP), a global leader in health technology and smart wearables, is thrilled to announce its participation in the CES Pepcom and ShowStoppers media events. Thes

News by Region

News by Industry

The largest press release distribution network in Korea

Global PR service

News by region

News by industry